Thursday, March 28, 2013In vitro maturation, including FSH priming, recovery of oocytes from 12-mm follicles, and using single blastocyst transfer, is safe and provides pregnancy rates up to 40% in patients with PCO.
Friday, March 1, 2013In vitro maturation should be performed only as an experimental procedure for carefully selected patients evaluating both efficacy and safety.
Altered insulin induced relaxation of aortic rings in a dihydrotestosterone induced rodent model of polycystic ovary syndrome
Monday, February 4, 2013Insulin-dependent vasorelaxation in aortic rings in a PCOS rat model is decreased (both NO-dependent or independent), and vitamin D treatment can improve only the NO-independent model.
The levels of hepatocyte growth factor in serum and follicular fluid and the expression of c Met in granulosa cells in patients with polycystic ovary syndrome
Wednesday, January 2, 2013The levels of follicular fluid and serum hepatocyte growth factor (HGF) and the expression of c-Met in polycystic ovary syndrome were determined along with the importance of HGF/c-Met signaling in fertilization success.
Thursday, November 29, 2012Reflections on "Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study" by Hagen et al.
Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women A prospective cohort study
Thursday, November 29, 2012Low AMH levels in young healthy women did not predict reduced fecundability. Even after exclusion of women with irregular cycles, the probability of conceiving was reduced in women with high AMH levels.
Does the level of serum antimullerian hormone predict ovulatory function in women with Polycystic Ovary Syndrome with aging
Thursday, September 27, 2012Anovulatory women with polycystic ovary syndrome (PCOS) and matched control subjects were followed for 5 years. Women with PCOS who had normal menses after 5 years had significantly lower initial serum antimullerian hormone levels.
Thursday, September 27, 2012Reflections on "High frequency of discordance between antimullerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in U.S. fertility centers"
Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel cyproterone acetate and drospirenone in patients with polycystic ovary syndrome
Thursday, September 27, 2012Therapeutic effects of three different oral contraceptive pills are comparable after 6 months of treatment. After 12 months, the cyproterone containing pill shows greater antiandrogenic effect. Effects on metabolic parameters are identical.
Tuesday, June 12, 2012Metformin activates adenosine monophosphate–activated protein kinase (AMPK) in rat ovarian thecainterstitial cells and subsequently inhibits cell proliferation and insulin-induced mitogenic signaling pathways.
Does ovulation induction with follicle-stimulating hormone still have a future in polycystic ovary syndrome?
Friday, June 8, 2012
Robert John Norman, M.D.…